Who owns CAMP?
Institutional ownership of CAMP4 Therapeutics Corporation from Form 13F, Q2 2026
61 institutional managers reported holding CAMP4 Therapeutics Corporation (CAMP) in Form 13F filings for Q2 2026, with 41,734,426 shares worth $182M. The largest reported holder was Jupiter Topco LLC. Managers that filed both quarters added a net 1,951,773 shares (+5.8%). 22 opened new positions and 7 sold out.
- Funds holding
- 61
- Value held
- $182M
- New / sold out
- 22 / 7
- Net shares, same filers
- +5.8%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of CAMP
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| Jupiter Topco LLC | $27.6M | 15.1% | 6,307,636 | First report |
| 5AM Venture Management, LLC | $25.6M | 14.1% | 5,869,091 | Unchanged |
| FMR LLC | $21.4M | 11.8% | 4,904,339 | Trimmed |
| Vivo Capital, LLC | $18.6M | 10.2% | 4,246,568 | Unchanged |
| Balyasny Asset Management L.P. | $11.3M | 6.2% | 2,575,724 | Trimmed |
| a16z Capital Management, L.L.C. | $9.3M | 5.1% | 2,125,339 | Unchanged |
| Adage Capital Partners GP, L.l.c. | $8.6M | 4.7% | 1,960,784 | Unchanged |
| Trails Edge Capital Partners, LP | $8.4M | 4.6% | 1,932,937 | Trimmed |
| BlackRock, Inc. | $7.2M | 3.9% | 1,644,134 | Added |
| Vanguard Capital Management LLC | $6.7M | 3.7% | 1,533,489 | Unchanged |
| Enavate Sciences GP, LLC | $6.2M | 3.4% | 1,425,541 | Trimmed |
| Stonepine Capital Management, LLC | $6.1M | 3.3% | 1,389,622 | Unchanged |
| HarbourVest Partners LLC | $5.6M | 3.0% | 1,271,948 | Unchanged |
| Geode Capital Management, LLC | $3.5M | 1.9% | 795,651 | Added |
| SummitTX Capital, L.P. | $3.2M | 1.7% | 725,160 | Added |
| Silverarc Capital Management, LLC | $2.9M | 1.6% | 653,594 | Unchanged |
| State Street Corp | $1.6M | 0.9% | 362,300 | Added |
| Northern Trust Corp | $1.1M | 0.6% | 248,673 | Added |
| Goldman Sachs Group Inc | $1.1M | 0.6% | 241,393 | Added |
| Vanguard Fiduciary Trust Co | $988K | 0.5% | 226,074 | Added |
| Vanguard Portfolio Management LLC | $965K | 0.5% | 220,717 | New |
| Birchview Capital, LP | $524K | 0.3% | 120,000 | New |
| Cantor Fitzgerald, L. P. | $468K | 0.3% | 107,000 | New |
| Two Sigma Investments, LP | $457K | 0.3% | 104,610 | Trimmed |
| Charles Schwab Investment Management Inc | $422K | 0.2% | 96,660 | Added |
Share of 13F holdings is each fund's shares as a share of the 41,734,426 CAMP shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- BlackRock, Inc. Added+$5.2M
- Geode Capital Management, LLC Added+$1.8M
- SummitTX Capital, L.P. Added+$1.7M
- Vanguard Portfolio Management LLC New+$965K
- State Street Corp Added+$941K
- Northern Trust Corp Added+$778K
- Goldman Sachs Group Inc Added+$713K
- Birchview Capital, LP New+$524K
- Cantor Fitzgerald, L. P. New+$468K
- Charles Schwab Investment Management Inc Added+$335K
Biggest sellers in Q2 2026
- Enavate Sciences GP, LLC Trimmed-$3.3M
- Susquehanna International Group, LLP Sold out-$1.5M
- 683 Capital Management, LLC Sold out-$476K
- Balyasny Asset Management L.P. Trimmed-$248K
- Millennium Management LLC Trimmed-$184K
- HRT Financial LP Sold out-$135K
- Hudson Bay Capital Management LP Trimmed-$130K
- FMR LLC Trimmed-$127K
- Barclays PLC Trimmed-$121K
- Qube Research & Technologies Ltd Sold out-$109K
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $15.2M and sold $6.7M; 15 added and 11 trimmed.
Schedule 13D and 13G filings on CAMP
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-11-12Adage Capital Management, L.P. SCHEDULE 13G filed by CAMP4 Therapeutics CorporationSchedule 13G
- 2026-05-15BALYASNY ASSET MANAGEMENT L.P. SCHEDULE 13G filed by CAMP4 Therapeutics CorporationSchedule 13G
- 2026-01-08JANUS HENDERSON GROUP PLC SCHEDULE 13G filed by CAMP4 Therapeutics CorporationSchedule 13G
- 2025-10-07FMR LLC SCHEDULE 13G filed by CAMP4 Therapeutics CorporationSchedule 13G
- 2025-05-14HARBOURVEST PARTNERS LLC SCHEDULE 13G filed by CAMP4 Therapeutics CorporationSchedule 13G
Questions about CAMP ownership
- Who owns CAMP stock?
- 61 institutional investment managers reported CAMP positions in their Form 13F filings for Q2 2026, holding 41,734,426 shares worth $182M in total. Jupiter Topco LLC reported the largest position.
- Are funds buying or selling CAMP?
- In Q2 2026, 22 managers opened new CAMP positions, 15 added, 11 trimmed and 7 sold out. Managers that filed in both quarters added a net 1,951,773 shares.
- How current is this CAMP institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to CAMP by CUSIP. Options are left out. CAMP news and filings · CAMP insider trades · Top funds